FibroGen Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for FibroGen, Inc. (FGEN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-47.58-284.23-293.65-290.02-189.29-76.97-86.42
Depreciation & Amortization2.699.9312.2114.8122.0517.746.56
Stock Based Compensation25.2250.7765.6071.1672.720.000.00
Change in Working Capital-117.46-119.6969.0360.08174.63-85.85-48.40
Change in Accounts Receivable-6.743.430.7725.18-11.970.000.00
Change in Inventory22.28-1.70-11.00-14.16-9.180.000.00
Change in Accounts Payable14.51-15.515.910.8117.730.000.00
Change in Other Working Capital-119.2232.371.04-9.38132.970.000.00
Other Operating Activities2.2332.3766.46130.7872.7166.371.12
Net Cash from Operating Activities-138.00-315.02-145.93-82.2381.60-78.71-76.14
Investing Activities
Capital Expenditures-0.27-2.523.74-5.19-3.995.76-7.84
Acquisitions0.000.66-35.00-25.000.000.000.00
Purchases of Investments-8.63-251.83-164.02-396.79456.480.000.00
Sales/Maturities of Investments133.84407.35127.85-25.00456.48125.77-514.29
Other Investing Activities0.006.737.384.217.77-411.300.00
Net Cash from Investing Activities125.99153.6689.12-426.97452.49120.02-522.12
Financing Activities
Debt Repayment-0.04-0.48-0.40-0.40-0.40-0.40-0.41
Common Stock Issued0.1448.414.1812.7037.8320.7829.85
Common Stock Repurchased-0.35-0.24-5.17-7.37-11.460.000.00
Other Financing Activities-0.35-2.9843.00-12.86-24.08-24.68-15.61
Net Cash from Financing Activities-0.26122.7546.78-0.5613.34-4.3013.88
Summary
Effect of Forex Changes on Cash0.75-3.40-5.482.604.700.00-0.01
Net Change in Cash-12.26-38.62-10.04-507.17552.1337.01-584.39
Cash at Beginning of Period113.69155.70171.22678.39126.2789.26673.66
Cash at End of Period102.18113.69155.70171.22678.39126.2789.26
Free Cash Flow-138.27-317.54-149.67-87.4277.61-84.46-84.16
Supplemental Disclosures
Interest Paid16.216.380.100.090.140.170.22